RxDoctor Payments Data

Patrick Daigle, MD

Family Medicine · Emerald Isle, NCNPI 1083683189

Payments from drug & device makers

$580in general payments, 2019–2025

Across 29 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214
  • Exact Sciences$83
  • Lilly USA, LLC$76
  • Pfizer$45
  • AstraZeneca$32
  • Amgen$29
  • plus $101 from 5 others

What the payments were for

  • Food & beverage$580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$580 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$122,643
Medicare patients
299
Services billed
2,760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide43$50,016
JardianceEmpagliflozin14$20,389
JanuviaSitagliptin Phosphate13$19,976
EliquisApixaban14$19,311
OzempicSemaglutide17$17,571
EntrestoSacubitril/Valsartan11$9,879
SymbicortBudesonide/Formoterol Fumarate27$7,801
Breo ElliptaFluticasone/Vilanterol19$7,663
Qvar RedihalerBeclomethasone Dipropionate12$3,743
BreynaBudesonide/Formoterol Fumarate17$3,003
Albuterol Sulfate HfaAlbuterol Sulfate97$2,466
Atorvastatin Calcium184$2,201
Celecoxib84$2,031
SynthroidLevothyroxine Sodium18$2,014
Omeprazole87$1,750

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$76$50,01643 claims
PfizerEliquis$45$19,31114 claims
Novo NordiskOzempic$25$17,57117 claims
AstraZenecaSymbicort$32$7,80127 claims
AbbVieSynthroid$214$2,01418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Emerald Isle

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →